Top 10 Railroad Stocks To Invest In 2016: ACADIA Pharmaceuticals Inc.(ACAD)
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on drug discovery and clinical development of novel treatments for central nervous system disorders. The company has a portfolio of four product candidates, including pimavanserin, which is in Phase III clinical development as a treatment for Parkinson's disease psychosis. It is also developing AGN-XX/YY, a product candidate in Phase II for chronic pain; and AC-262271, a product candidate in Phase I for glaucoma in collaboration with Allergan, as well as AM-831, a product candidate in IND-track development in collaboration with Meiji Seika Kaisha, Ltd. In addition, ACADIA Pharmaceuticals Inc. is developing two preclinical programs in the area of Parkinson?s disease. The product candidates in the company?s pipeline emanate from discoveries made using its proprietary drug discovery platform. The company was founded in 1993 and is headquartered in San Diego, California.
Advisors' Opinion:- [By Brian Orelli]
There goes the short-term bear thesis on ACADIA Pharmaceuticals (NASDAQ: ACAD ) .
I had recommended staying away from the company for now because it looked too risky with a long wait before the company could complete its second phase 3 trial for pimavanserin in patients with Parkinson's disease psychosis.
source from Top Penny Stocks For 2015:http://www.seekpennystocks.com/top-10-railroad-stocks-to-invest-in-2016.html
No comments:
Post a Comment